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Direct link to deposited data {#s0010}
=============================

<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57255>

Experimental design, materials and methods {#s0015}
==========================================

Cell culture {#s0020}
------------

Early passage DPSCs (P1--P2) isolated from deciduous teeth have been obtained from Dr. Songtao Shi (Univ. of Southern California) and cultured in alpha-MEM supplemented with 20% fetal bovine serum (v/v), 2 mM [l]{.smallcaps}-glutamine, 100 μM [l]{.smallcaps}-ascorbate-2-phosphate, 50 u/ml penicillin and 50 μg/ml streptomycin [@bb0005]. Exponentially growing DPSCs were treated with different concentrations of ethanol diluted from absolute ethanol (FW = 21.7 M). For acute exposure, cells were fed with media containing given concentrations of ethanol (0, 1, 5, 10, 20, 50 mM) for 24 or 48 h.

RNA isolation {#s0025}
-------------

Total RNA was isolated from DPSCs treated with ethanol (0, 1, 5, 10, 20, 50 mM) for 24 or 48 h. RNA was extracted using RNeasy purification kit, following the manufacturer\'s instruction (Qiagen, Valencia, CA). Isolated RNA was further purified by DNase treatment (Ambion/Life Technologies, Grand Island, NY). RNA purity and concentration were determined by NanoDrop, ND-1000 spectrophotometer (Thermo Scientific, Indianapolis, IN) and microfluidics-based platform 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). RNA concentration ranged from 56.3 ng/μl to 109 ng/μl. RNA concentration ≥ 50 ng/μl is recommended. 260/280 ratio ranged from 2.01 to 2.09. Ideal 260/280 ratio for pure RNA is 2.0.

Gene expression microarray analysis {#s0030}
-----------------------------------

Biological duplicate samples were hybridized to Affymetrix Human Genome Plus 2.0 (Cat.\# 900469). We set the target intensity (TGT) at 500. The sensitivity of the system was measured by %P using the 3′ biased Affymetrix HG-U133A 2.0 arrays. %P ranged from 41.1 to 45.1% demonstrating the ability to detect a large number of transcripts across a wide range of abundance. All 24 arrays were assessed for recommended standard quality control metrics by Affymetrix including image quality, signal distribution and pair wise scatter plots and passed. mas5.CHP files were generated for each array by MAS 5.0 (Affymetrix, Santa Clara, CA) and combined to a final RESULTS.MAS5.TXT file.

Data analysis {#s0035}
-------------

Degradation plot was prepared with each curve corresponding to a single chip and visualizing the chip-averaged dependency between probe intensity and probe position ([Fig. 1](#f0005){ref-type="fig"}A). Raw data was initially analyzed for the quality of microarray analysis by log density estimates of the data across all arrays ([Fig. 1](#f0005){ref-type="fig"}B).

We performed background correction ([Fig. 2](#f0010){ref-type="fig"}), quantile normalization and log transformation with Robust Multi-array Average (RMA) approach on Affymetrix gene expression data using "Affy" R package ([Fig. 3](#f0015){ref-type="fig"}) [@bb0010].

We removed probes with expression lower than the overall sample median; 27,327 out of 54,676 probes were kept for further analysis ([Fig. 3](#f0015){ref-type="fig"}). Given that the sensitivity of array platforms is generally considered lower than deep sequencing (with enough sequence depth), clearly a significant percentage of genes are either not expressed or beyond the detection limit in a typical array experiment. Filtering out this group of genes would potentially be beneficial to DEG (differentially expressed gene) detection.

Principal Component Analysis was performed to detect expression data separation by EtOH treatment time ([Fig. 4](#f0020){ref-type="fig"}A) and by doses ([Fig. 4](#f0020){ref-type="fig"}B). Treatment time shows quite consistent grouping irrespective of doses, but doses in combination of treatment time show high degree of variations in gene expression.

We constructed linear regression models to evaluate the effect of dose and time on gene expression ([Fig. 5](#f0025){ref-type="fig"}). For each gene we fit a separate model in terms of dose, time, and the dose by time interaction effect. In these models dose was treated as a continuous variable. In addition to the linear model, we performed a regression spline analysis with moderated F-test to detect the probes differentially expressed over time with increasing dose, with the assumption that expression changes smoothly along with the increasing of the dose rather than making discrete jumps from one dose to another. "Limma" R packages were used for this analysis. Q-values were generated to control the false discovery rate using "Qvalue" R package (<http://www.bioconductor.org/packages/release/bioc/html/qvalue.html>). A set of significant probes with cut-off of p \< 0.05 for interaction effects was selected from each model for further functional analysis. All statistical analysis was performed using R-3.0.2 (<http://cran.r-project.org/bin/windows/base/old/3.0.2/>).
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![A. Degradation plot: Each curve corresponds to a single chip and visualizes the chip-averaged dependency between probe intensity and probe position. B. Log density estimates (histograms) of the data across arrays.](gr1){#f0005}

![Quality control stats. Each array is presented by a separated line. The blue bar represents the region where all scale factors fall within 3 fold of the mean scale factor for all chips. The chips passed all the QC metrics except that less than 30% absence of BioB is pointed to flag, indicating adequate quality data with acceptable inefficiency in hybridization step.](gr2){#f0010}

![Boxplot of intensity for each sample on (A) raw data and (B) after normalization and log transformation using Robust Multi-array Average (RMA) method.](gr3){#f0015}

![Principal Component Analysis (PCA). PCA was performed on RMA dataset after filtering 50% probes with low expression and reducing original 54,676 probes to 27,327 probes. A. Separation by treatment time and B. separation by EtOH doses.](gr4){#f0020}

![Interaction from linear model ranked by Q values.](gr5){#f0025}
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